search
Back to results

COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box

Primary Purpose

COVID-19

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
COVID-19 barrier box
Sponsored by
University of British Columbia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for COVID-19 focused on measuring Personal protective equipment, Barrier box

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Patient Participant Inclusion Criteria:

  1. Healthy American Society of Anesthesiologists (ASA) Classification 1 or 2 adults scheduled for elective surgery requiring orotracheal intubation
  2. 18 years of age or older
  3. COVID negative (As defined by negative COVID swab plus absence of screening symptoms as defined by: Fever, Cough, Shortness of breath or difficulty breathing, Chills, Repeated shaking with chills, Muscle pain, Headache, Sore throat, New loss of taste or smell)

Anesthesiologist Participant Inclusion Criteria:

  1. Attending Anesthesiologist
  2. Have performed at least 5 prior intubations using McGrath videolaryngoscopes
  3. Have performed at least 5 prior endotracheal intubations with the locally instituted COVID-related modifications
  4. Must not have more than one prior experience with using the COVID barrier box on real patients (Prior to the study start; not inclusive of intubations done in the context of this study)
  5. Have performed at least one practice intubation on a manikin with the COVID barrier box prior to initiation of study

Patient Participant Exclusion Criteria:

  1. Patient refusal, inability to consent or cooperate
  2. Claustrophobia
  3. Body habitus not allowing physical fit into COVID barrier box
  4. History of documented difficult airway
  5. Risk factors for difficult airway (Mallampati 3 or 4, thyromental distance less than 6 cm, interincisor distance less than 4 cm, upper lip bite test 2 or 3, body mass index (BMI) 30 or above, macroglossia, airway edema, blood in airway, cervical immobility, or any other concerning features deemed by attending anesthesiologist)
  6. Risk factors for gastric aspiration
  7. Allergy to rocuronium

Anesthesiologist Participant Exclusion Criteria:

  1. Refusal to consent
  2. Do not meet any of the inclusion criteria

Sites / Locations

  • Providence Health Care

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

COVID-19 barrier box intervention group

Control group

Arm Description

Attending anesthesiologists will use a COVID-19 barrier box for intubating the patient participants of this group.

Attending anesthesiologists will use standard intubation procedures.

Outcomes

Primary Outcome Measures

Time to tracheal intubation (TTI)
TTI is the time from when the laryngoscope blade passes between the patient's lips until the first upstroke of the capnograph trace. TTI will be measured by a third party observer outside of the operating room.

Secondary Outcome Measures

First pass success rate
A first pass success refers to successful insertion of the McGRATH™ videolaryngoscope or endotracheal tube by an anesthesiologist on the first-attempt without withdrawing from the mouth in no longer than 150 seconds.
Total time of airway manipulation
This refers to the time from the face mask seal being lifted to the first upstroke of the capnograph trace.
Number of intubation attempts
Participant anesthesiologists will report the number of intubation attempts that were needed to achieve successful intubation.
Number of Operators needed for intubation
Participant anesthesiologists will report the number of operators needed to assist in successfully intubating the participant.
Number of alternative techniques used for intubation
Participant anesthesiologists will report the number of alternative techniques used for intubation (if any) i.e. repositioning of patient, change of materials (blade, endotracheal (ET) tube, addition of stylette), change in approach (nasotracheal vs orotracheal), use of another technique (Fibreoptic bronchoscopy, intubating laryngeal mask airway (LMA)
Cormack-Lehane Grade for the first attempt of intubation
Participant anesthesiologists will report the Cormack-Lehane Grade for the first attempt of intubation.
Lifting force applied on laryngoscope blade
Participant anesthesiologists will report if the lifting force applied on laryngoscope blade was normal or increased.
Laryngeal pressure application
Participant anesthesiologists will report if laryngeal pressure, such as Backward Upward Rightward Pressure (BURP) not inclusive of cricoid pressure was applied or not.
Vocal cord position
Participant anesthesiologists will report the vocal cord position (either abduction or adduction).
Anesthesiologist perception of intubation difficulty
Participant anesthesiologists will report the difficulty experienced during the intubation from a scale of 0 to 10 with 0 being without difficulty and 10 being maximum difficulty.
Anesthesiologist perception of contributors to difficulty in intubation, if any
Participant anesthesiologists will report any contributors to difficulties in intubation, or state "none", if no difficulties were experienced.
Patient acceptability of the COVID Barrier Box
Patients from the intervention group will report the acceptability of COVID barrier box. They will be asked "How acceptable did you find the use of the COVID barrier box?" and respond on a five-point scale (acceptable, slightly acceptable, neutral, slightly unacceptable, unacceptable).
Patient comfort with the COVID Barrier Box
Patients from the intervention group will report their level of comfort experienced with the use of the COVID barrier box. They will be asked "How comfortable did you find the use of the COVID barrier box?" and will respond on a five-point scale (comfortable, slightly comfortable, neither, slightly uncomfortable, uncomfortable).
Patient comments on the COVID Barrier Box
Patients from the intervention group will report any comments that they have on the COVID barrier box.

Full Information

First Posted
April 24, 2020
Last Updated
February 23, 2021
Sponsor
University of British Columbia
search

1. Study Identification

Unique Protocol Identification Number
NCT04366141
Brief Title
COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box
Official Title
The Impact of a Barrier Enclosure on Endotracheal Intubation Duration and First Pass Attempt - A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
May 1, 2020 (Actual)
Primary Completion Date
February 1, 2021 (Actual)
Study Completion Date
February 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of British Columbia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The trial will be done to determine the impact of a barrier enclosure, COVID (coronavirus disease -19) barrier box on endotracheal intubation attempts, and duration. This study will be a prospective, open-label, randomized controlled trial. A total of 100 patients scheduled for elective surgery will be randomly assigned in two groups (intervention group and control group). Participating attending anesthesiologists will intubate the intervention group patients with COVID barrier box and the control group patients without the box. The anesthesiologists and the intervention group patients will be surveyed about their perception after the surgery. The result of this study will help in decision making about using COVID barrier box to minimize the viral transmission from patients to healthcare workers during the pandemic.
Detailed Description
Purpose: To assess the time to tracheal intubation (TTI) and first-pass success rate for attending anesthesiologists intubating with COVID-related modifications with or without the use of a COVID barrier box. Hypothesis: Using a COVID barrier box for tracheal intubation with COVID-related modifications for attending anesthesiologists would be prolonged compared to not using one. Justification: Tracheal intubation is a high-risk time point for attending anesthesiologists to contract COVID. This risk can be minimized by using a proprietary barrier enclosure, COVID barrier box covering a patient's head and neck during intubation. It is crucial to estimate the intubation time and first-pass success rate of using a COVID barrier box for introducing it to intubate critically ill COVID patients. The finding of this study can lead to a ground-breaking measure to minimize viral transmission to healthcare workers during the pandemic. Objectives: The primary objective of the study is to determine the TTI as measured by an observer. The secondary objectives are to assess the first-pass success rate, the total time of airway manipulation, as well as anesthesiologists' perception of intubation difficulty, and patients' satisfaction. Research Design: This study will be a prospective, open-label, randomized controlled trial. Consented eligible patients will be randomly allocated in a 1:1 ratio to intervention or control groups. A computer-generated sequence of random numbers will be used to randomize patients between groups. Consented eligible attending anesthesiologists will use COVID barrier box for intubating the intervention group but not for the control group. Each anesthesiologist will perform one practice intubation on manikins with the COVID barrier box before initiation of the study. The locally instituted COVID-related modifications will be in place during the practice intubation and intubations during surgery for both groups. A third party observer will monitor intubation time. All attending anesthesiologists and intervention group patients will undertake a post-survey. Statistical Analysis: A total of 100 patients with 50 in each group will be included in the study to ensure 99% power to detect a clinically significant TTI difference. Data distribution will be assessed using the Shapiro-Wilk and D'Agostino tests. Time outcomes will be analyzed using t-test or Mann-Whitney test. The first-pass success rate and categorical data about intubation difficulty and patient satisfaction will be analyzed using Fisher's Exact test.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19
Keywords
Personal protective equipment, Barrier box

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This will be a prospective, open-label, randomized controlled trial in which patients will be randomly allocated to two study groups on a 1:1 basis into: COVID-19 barrier box Intervention group: Anesthesiologists will use a COVID barrier box during intubation. Control group: Anesthesiologists will not use a COVID barrier box during intubation. Standard intubation procedures will be followed for intubation. A block randomization strategy, using a computer-generated sequence of random numbers, will be used. Randomization will occur preoperatively if consented patients meet the eligibility criteria and provide informed consent.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
COVID-19 barrier box intervention group
Arm Type
Experimental
Arm Description
Attending anesthesiologists will use a COVID-19 barrier box for intubating the patient participants of this group.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Attending anesthesiologists will use standard intubation procedures.
Intervention Type
Device
Intervention Name(s)
COVID-19 barrier box
Intervention Description
Attending anesthesiologists will use a plastic proprietary barrier enclosure for intubating patients in the intervention group to protect spreading aerosolized droplets from patient to health care provider.
Primary Outcome Measure Information:
Title
Time to tracheal intubation (TTI)
Description
TTI is the time from when the laryngoscope blade passes between the patient's lips until the first upstroke of the capnograph trace. TTI will be measured by a third party observer outside of the operating room.
Time Frame
This will be measured at the time of intubation for an elective surgical patient. It will take approximately 5 minutes.
Secondary Outcome Measure Information:
Title
First pass success rate
Description
A first pass success refers to successful insertion of the McGRATH™ videolaryngoscope or endotracheal tube by an anesthesiologist on the first-attempt without withdrawing from the mouth in no longer than 150 seconds.
Time Frame
This will be measured at the time of intubation for an elective surgical patient within 150 seconds of initiating the first attempt to intubate.
Title
Total time of airway manipulation
Description
This refers to the time from the face mask seal being lifted to the first upstroke of the capnograph trace.
Time Frame
This will be measured at the time of intubation for an elective surgical patient. It will take approximately 5 minutes.
Title
Number of intubation attempts
Description
Participant anesthesiologists will report the number of intubation attempts that were needed to achieve successful intubation.
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Number of Operators needed for intubation
Description
Participant anesthesiologists will report the number of operators needed to assist in successfully intubating the participant.
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Number of alternative techniques used for intubation
Description
Participant anesthesiologists will report the number of alternative techniques used for intubation (if any) i.e. repositioning of patient, change of materials (blade, endotracheal (ET) tube, addition of stylette), change in approach (nasotracheal vs orotracheal), use of another technique (Fibreoptic bronchoscopy, intubating laryngeal mask airway (LMA)
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Cormack-Lehane Grade for the first attempt of intubation
Description
Participant anesthesiologists will report the Cormack-Lehane Grade for the first attempt of intubation.
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Lifting force applied on laryngoscope blade
Description
Participant anesthesiologists will report if the lifting force applied on laryngoscope blade was normal or increased.
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Laryngeal pressure application
Description
Participant anesthesiologists will report if laryngeal pressure, such as Backward Upward Rightward Pressure (BURP) not inclusive of cricoid pressure was applied or not.
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Vocal cord position
Description
Participant anesthesiologists will report the vocal cord position (either abduction or adduction).
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Anesthesiologist perception of intubation difficulty
Description
Participant anesthesiologists will report the difficulty experienced during the intubation from a scale of 0 to 10 with 0 being without difficulty and 10 being maximum difficulty.
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Anesthesiologist perception of contributors to difficulty in intubation, if any
Description
Participant anesthesiologists will report any contributors to difficulties in intubation, or state "none", if no difficulties were experienced.
Time Frame
This will be filled out as part of a questionnaire after intubation is completed. It will take approximately 10 minutes to complete the full questionnaire..
Title
Patient acceptability of the COVID Barrier Box
Description
Patients from the intervention group will report the acceptability of COVID barrier box. They will be asked "How acceptable did you find the use of the COVID barrier box?" and respond on a five-point scale (acceptable, slightly acceptable, neutral, slightly unacceptable, unacceptable).
Time Frame
This question will be asked as part of a short questionnaire administered to patients when they meet the Post Anesthesia Care Unit (PACU) discharge criteria (usually 2 to 5 hours after surgery). It will take about 10 minutes to complete.
Title
Patient comfort with the COVID Barrier Box
Description
Patients from the intervention group will report their level of comfort experienced with the use of the COVID barrier box. They will be asked "How comfortable did you find the use of the COVID barrier box?" and will respond on a five-point scale (comfortable, slightly comfortable, neither, slightly uncomfortable, uncomfortable).
Time Frame
This question will be asked as part of a short questionnaire administered to patients when they meet the Post Anesthesia Care Unit (PACU) discharge criteria (usually 2 to 5 hours after surgery). It will take about 10 minutes to complete.
Title
Patient comments on the COVID Barrier Box
Description
Patients from the intervention group will report any comments that they have on the COVID barrier box.
Time Frame
This question will be asked as part of a short questionnaire administered to patients when they meet the Post Anesthesia Care Unit (PACU) discharge criteria (usually 2 to 5 hours after surgery). It will take about 10 minutes to complete.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Patient Participant Inclusion Criteria: Healthy American Society of Anesthesiologists (ASA) Classification 1 or 2 adults scheduled for elective surgery requiring orotracheal intubation 18 years of age or older COVID negative (As defined by negative COVID swab plus absence of screening symptoms as defined by: Fever, Cough, Shortness of breath or difficulty breathing, Chills, Repeated shaking with chills, Muscle pain, Headache, Sore throat, New loss of taste or smell) Anesthesiologist Participant Inclusion Criteria: Attending Anesthesiologist Have performed at least 5 prior intubations using McGrath videolaryngoscopes Have performed at least 5 prior endotracheal intubations with the locally instituted COVID-related modifications Must not have more than one prior experience with using the COVID barrier box on real patients (Prior to the study start; not inclusive of intubations done in the context of this study) Have performed at least one practice intubation on a manikin with the COVID barrier box prior to initiation of study Patient Participant Exclusion Criteria: Patient refusal, inability to consent or cooperate Claustrophobia Body habitus not allowing physical fit into COVID barrier box History of documented difficult airway Risk factors for difficult airway (Mallampati 3 or 4, thyromental distance less than 6 cm, interincisor distance less than 4 cm, upper lip bite test 2 or 3, body mass index (BMI) 30 or above, macroglossia, airway edema, blood in airway, cervical immobility, or any other concerning features deemed by attending anesthesiologist) Risk factors for gastric aspiration Allergy to rocuronium Anesthesiologist Participant Exclusion Criteria: Refusal to consent Do not meet any of the inclusion criteria
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anton Chau, MD
Organizational Affiliation
University of British Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Providence Health Care
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V6Z 1Y6
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22563403
Citation
Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7(4):e35797. doi: 10.1371/journal.pone.0035797. Epub 2012 Apr 26.
Results Reference
background
PubMed Identifier
32243118
Citation
Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier Enclosure during Endotracheal Intubation. N Engl J Med. 2020 May 14;382(20):1957-1958. doi: 10.1056/NEJMc2007589. Epub 2020 Apr 3. No abstract available.
Results Reference
background
PubMed Identifier
25493156
Citation
Sakles JC, Mosier J, Patanwala AE, Dicken J. Learning curves for direct laryngoscopy and GlideScope(R) video laryngoscopy in an emergency medicine residency. West J Emerg Med. 2014 Nov;15(7):930-7. doi: 10.5811/westjem.2014.9.23691. Epub 2014 Oct 29.
Results Reference
background
PubMed Identifier
23736891
Citation
Mohr S, Weigand MA, Hofer S, Martin E, Gries A, Walther A, Bernhard M. Developing the skill of laryngeal mask insertion: prospective single center study. Anaesthesist. 2013 Jun;62(6):447-52. doi: 10.1007/s00101-013-2185-7. Epub 2013 Jun 6.
Results Reference
background
PubMed Identifier
17042849
Citation
Maharaj CH, O'Croinin D, Curley G, Harte BH, Laffey JG. A comparison of tracheal intubation using the Airtraq or the Macintosh laryngoscope in routine airway management: A randomised, controlled clinical trial. Anaesthesia. 2006 Nov;61(11):1093-9. doi: 10.1111/j.1365-2044.2006.04819.x.
Results Reference
background
PubMed Identifier
27983871
Citation
Joshi R, Hypes CD, Greenberg J, Snyder L, Malo J, Bloom JW, Chopra H, Sakles JC, Mosier JM. Difficult Airway Characteristics Associated with First-Attempt Failure at Intubation Using Video Laryngoscopy in the Intensive Care Unit. Ann Am Thorac Soc. 2017 Mar;14(3):368-375. doi: 10.1513/AnnalsATS.201606-472OC.
Results Reference
background
PubMed Identifier
19522050
Citation
Savoldelli GL, Schiffer E, Abegg C, Baeriswyl V, Clergue F, Waeber JL. Learning curves of the Glidescope, the McGrath and the Airtraq laryngoscopes: a manikin study. Eur J Anaesthesiol. 2009 Jul;26(7):554-8. doi: 10.1097/eja.0b013e3283269ff4.
Results Reference
background
PubMed Identifier
26336853
Citation
Wallace CD, Foulds LT, McLeod GA, Younger RA, McGuire BE. A comparison of the ease of tracheal intubation using a McGrath MAC((R)) laryngoscope and a standard Macintosh laryngoscope. Anaesthesia. 2015 Nov;70(11):1281-5. doi: 10.1111/anae.13209. Epub 2015 Sep 4.
Results Reference
background
PubMed Identifier
19104167
Citation
Nouruzi-Sedeh P, Schumann M, Groeben H. Laryngoscopy via Macintosh blade versus GlideScope: success rate and time for endotracheal intubation in untrained medical personnel. Anesthesiology. 2009 Jan;110(1):32-7. doi: 10.1097/ALN.0b013e318190b6a7.
Results Reference
background
PubMed Identifier
32221970
Citation
Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia. 2020 Jun;75(6):785-799. doi: 10.1111/anae.15054. Epub 2020 Apr 1.
Results Reference
background
PubMed Identifier
18635480
Citation
Jones PM, Armstrong KP, Armstrong PM, Cherry RA, Harle CC, Hoogstra J, Turkstra TP. A comparison of glidescope videolaryngoscopy to direct laryngoscopy for nasotracheal intubation. Anesth Analg. 2008 Jul;107(1):144-8. doi: 10.1213/ane.0b013e31816d15c9.
Results Reference
background
PubMed Identifier
25721326
Citation
Yao WL, Wan L, Xu H, Qian W, Wang XR, Tian YK, Zhang CH. A comparison of the McGrath(R) Series 5 videolaryngoscope and Macintosh laryngoscope for double-lumen tracheal tube placement in patients with a good glottic view at direct laryngoscopy. Anaesthesia. 2015 Jul;70(7):810-7. doi: 10.1111/anae.13040. Epub 2015 Feb 27.
Results Reference
background
Citation
CDC. Coronavirus Disease 2019 (COVID-19) - Symptoms [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2020 Apr 20]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
Results Reference
background
Citation
Chan A. Should we use an "aerosol box" for intubation? :11.
Results Reference
background
PubMed Identifier
33973161
Citation
Jen TTH, Gusti V, Badh C, Mehta S, Denomme J, Lockhart S, Shams B, Klaibert B, Chau A. The impact of a barrier enclosure on time to tracheal intubation: a randomized controlled trial. Can J Anaesth. 2021 Sep;68(9):1358-1367. doi: 10.1007/s12630-021-02024-z. Epub 2021 May 10.
Results Reference
derived

Learn more about this trial

COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box

We'll reach out to this number within 24 hrs